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CASE PRESENTATION

A Case of Disseminated Nocardia beijingensis Manifesting as
Subcutaneous and CNS Nocardiosis in an Immunocompetent
Patient
Scott Cathcart, MD,1 Patricia Stogsdill, MD,2 Rebecca Bell3
Department of Internal Medicine, Maine Medical Center, Portland, ME, 2Department of Infectious Diseases, Maine Medical
Center, Portland, ME, 3Tufts Medical School, Boston, MA
1

Introduction:

Nocardiosis is an uncommon infection, typically encountered in immunocompromised patients. Only 5
cases have been reported in the United States. We present a case of disseminated Nocardia beijingensis
involving the lung, subcutaneous tissue, and central nervous system of an immunocompetent patient.

Clinical Findings: A 60-year-old immunocompetent male with no significant medical history presented to our hospital after
a complicated medical course, beginning with vague respiratory complaints. His initial work-up revealed
a large mass of unclear etiology in the right upper lung. A month later, he had a syncopal episode and
then developed focal neurologic deficits.
Diagnosis,
Interventions,
and Outcomes:

Sputum cultures obtained after the patient’s syncopal episode grew gram-positive rods. Results of a
computed tomography of the chest showed a new 17-mm subcutaneous mass. The mass was biopsied,
which revealed gram-positive rods with partial acid-fast staining. Week later, results of magnetic
resonance imaging of his brain showed multiple enhancing lesions with vasogenic edema scattered
throughout. A tissue culture from his chest mass was sent to the Mayo Clinic and ultimately grew
Nocardia beijingensis. The patient was started on the appropriate antibiotic therapy and has made
significant clinical improvement.

Conclusions:

Though Nocardia is often associated with an immunocompromised state, it can also occur in patients
with pulmonary findings and evidence of disseminated disease, particularly central nervous system
manifestations, regardless of immune status. A high index of suspicion is needed, as definitive diagnosis
often takes weeks due to the slow-growing nature of Nocardia species.
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CASE PRESENTATION
The patient was a pleasant, albeit anxious,
gentleman with a greater than 20-year history of
right-side neck pain following a remote trauma, as
well as post-traumatic stress disorder. In March
2019, the patient was seen by his primary care
physician after 2 months of progressive cough
with associated wheezing, fevers, sweats, and
chest/back pain. The results of his chest x-ray
were negative, but the results of his follow-up CT
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(computed tomography) revealed a large mass in
his right apical lung (Figure 1).
Three days after the CT, the patient was evaluated
in the emergency department (ED), where his
health care provider was initially concerned about
malignancy vs tuberculosis. The results of a
T-spot were negative. He was given amoxacillinclavulanate for post-obstructive pneumonia.
Two days later, the results of his follow-up PET
(positron emission tomography) scan showed a
6- to 7-cm mass in his right upper lobe that was
strongly positive for fluorodeoxyglucose. This result
suggested a primary lung malignancy/Pancoast
tumor, especially in the context of fevers, night
sweats, and weight loss. Interestingly, he showed
1
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Figure 1. Computed tomography of the chest revealing
large mass in right apical lung.

a lack of mediastinal adenopathy. The results of
a subsequent CT-guided biopsy revealed chronic
inflammatory changes consistent with pneumonia
and no evidence of neoplasm. He failed to improve
with amoxacillin-clavulanate. He was transitioned to
levofloxacin and a prednisone taper due to concern
for bronchiolitis obliterans organizing pneumonia,
and he continued his 3-week course of antibiotics.
This treatment appeared to provide some benefit,
but his condition deteriorated when antibiotics were
stopped. A bronchoscopy was performed 1 month
after his initial presentation to the ED, but the results
were negative for Pneumocystis jiroveci, as were
the results following fungal silver stain, cytology for
malignancy, and acid-fast staining and culture. He
was given a 5-day steroid burst after the procedure,
again without improvement.
He presented to the ED again after a syncopal
episode several days after the bronchoscopy with
a leukocytosis of 30,000 (90% polymorphonuclear),
fevers to 102ºF, and complaints of intermittent
hemoptysis. The patient was given broad-spectrum
antibiotics (meropenem and vancomycin) as his
presentation was again thought to be due to a
bacterial process, and he had responded positively
to antibiotics in the past. Sputum cultures eventually
grew gram-positive rods. The results of a CT of the
chest during this stay revealed a stable infiltrate in
the right upper lung with new tree-in-bud opacities
and mild ground-glass opacities, consistent with
multifocal pneumonia. The results also noted a new
https://knowledgeconnection.mainehealth.org/jmmc/vol2/iss2/13
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17-mm subcutaneous mass on his chest at the level
of the sternum. Results from a biopsy of this lesion
revealed gram-positive rods with partial acid-fast
staining, concerning for Actinomyces or Nocardia,
similar to those identified in the sputum cultures
obtained on his admission. The culture was sent
to the Mayo Clinic for speciation and susceptibility
testing. Given the patient’s immunocompetent state
(he was HIV-negative and lacked other comorbid
conditions), Actinomyces was favored over
Nocardia, and he was given IV penicillin in addition
to meropenem. This treatment was further tailored
to oral trimethoprim-sulfamethoxazole (800/160
mg, 2 times daily) and penicillin V (500 mg, 4 times
daily) before discharging him on hospital day 10. He
was discharged with plans for indefinite antibiotics
and follow-up with his pulmonologist. During this
admission, an extensive work-up for possible
fungal etiologies was performed. The results were
negative for Cryptococcus, coccidioidomycosis,
and histoplasmosis. A CT of his head was also
conducted to further evaluate the patient’s syncope.
The result of the CT showed 2 discrete focal
hypodensities within the right and left parietal graywhite junctions with surrounding edema, which
were concerning for metastatic disease vs focal
areas of hemorrhage. This finding was not worked
up further.
The patient initially did well on this regimen. At a
follow-up appointment with his pulmonologist a
week after discharge, he reported feeling much
better, his fevers and hemoptysis resolved, and he
noticed a decrease in his night sweats. However,
his cough persisted. He subsequently developed
issues with balance and double-vision, particularly
with an extreme upward gaze, which prompted his
return to the ED a week later. The results of an MRI
of his brain revealed “multiple enhancing lesions
with vasogenic edema scattered throughout,” which
was consistent with an infectious process in his
central nervous system (CNS), with disseminated
Nocardia the most likely organism (Figure 2).
He was given IV meropenem, IV trimethoprimsulfamethoxazole, and steroids, and then
transferred to our facility for a higher level of care.
A transesophageal echo was obtained to rule out
endocarditis. An MRI of his spine was performed
to look for osteomyelitis. Results of imaging of his
cervical spine raised the possibility of osteomyelitis
with abnormal prevertebral edema at the level of
C5/C6, which was not seen in the results of an
2
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and no evidence of discitis. The patient continued
to have double-vision at the periphery as a result of
these resolving brain lesions. Five months later, the
results of another MRI of the brain showed a further
decrease in size and signal intensity of the focal
areas of signal hyperintensity, as well as resolution
of signal enhancement, compared to prior imaging.

DISCUSSION

Figure 2. T2-weighted magnetic resonance imaging
of the brain with multiple enhancing lesions and
vasogenic edema

MRI obtained several months earlier. A peripherally
inserted central catheter line was placed, and the
patient was discharged on 6 weeks of IV antibiotics
(trimethoprim-sulfamethoxazole and meropenem)
and close follow-up with infectious diseases.
Culture data returned from the Mayo Clinic, which
revealed Nocardia beijingensis. After completing 5
weeks of IV antibiotics, he was transitioned to per
os trimethoprim-sulfamethoxazole with a plan to
continue therapy for an additional 12 months.
Two months after his diagnosis (almost 4 months
after his initial ED presentation), the patient ceased
to experience night sweats or cough, and he began
to regain strength and daily functioning. However,
his posterior neck pain and radicular symptoms
down his right side persisted. The results of a followup chest CT at this time showed that the mass-like
consolidation in the right upper lobe had nearly
resolved. The results of an MRI of his brain 1 month
later revealed a marked interval decrease in the
size and number of enhancing parenchymal lesions
when compared to results from 2 months earlier.
The adjacent vasogenic edema also significantly
decreased. The results of an MRI of the spine at the
same time was consistent with ongoing Nocardia
osteomyelitis, with decreased prevertebral edema
Published by MaineHealth Knowledge Connection, 2020

The genus Nocardia is a ubiquitous group of grampositive bacilli found in the environment, primarily
in soil, but also in decomposing organic matter
and both fresh water and saltwater. These bacteria
are thought to play a role in the soil ecosystem
and can cause significant disease in susceptible
hosts.1,2 More than 50 species have been identified.
Of these, the most common are the Nocardia
asteroides complex, which have been reorganized
into several different species based on their
differing drug susceptibilities.1 Nocardia species
are typically opportunistic organisms, but up to onethird of patients are immunocompetent. Pulmonary
nocardiosis is the most common presentation,
as inhalation is the primary route of inoculation,
and is often difficult to differentiate from fungal
and mycobacterial infections. Extrapulmonary
manifestations due to disseminated disease are
common. The most common sites for dissemination
include the CNS, skin and subcutaneous tissues,
eyes, kidneys, joints, bones, and the heart. The
CNS is affected in approximately one-third of
all cases. Primary cutaneous and soft-tissue
nocardial lesions can occur following traumatic
skin injuries contaminated with soil, typically in
immunocompetent hosts.1,3
In 2001, Nocardia beijingensis was first identified
after being isolated from a mud sample taken from
a sewage ditch in Beijing.2 In 2004, the first human
infections were reported in Thailand and Japan.4 In
2014, the first case of Nocardia beijingensis was
reported in the United States. The case involved
an immunocompetent patient at the Mayo Clinic
Florida.5 Since 2014, only 5 additional cases
of Nocardia beijingensis have been reported in
the Western hemisphere. Of these, 3 occurred
in immunocompetent hosts, and all 3 were in
Florida.6-10 The most recent report by Chauhan, in
2019, was the only case in the United States that
involved the CNS.9 Ours is the second reported
case of CNS nocardiosis in the United States, and
the first with multiple simultaneous manifestations of
disseminated nocardiosis. Our immunocompetent
3
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patient developed primary pulmonary disease,
which spread to the subcutaneous tissue overlying
his sternum and to his brain. The diagnosis was
ultimately made based on a tissue biopsy of his
sternal lesion, and the CNS lesions were assumed
to be of the same etiology.
Pulmonary nocardiosis typically presents as
subacute pneumonia, with symptoms developing
over days or weeks. Less common is an acute
presentation with symptoms such as dyspnea,
pleuritic pain, and hemoptysis.11 CNS nocardiosis
is also variable in presentation, most often
manifesting as focal neurologic deficits, headache,
fever, and seizures. CNS nocardiosis appears as
ring-enhancing lesions on brain imaging and is
often initially misdiagnosed as tumor or abscess.12
Clinical diagnosis is difficult, given the varied and
nonspecific presentations. The current diagnostic
gold standard is a positive microbiological culture
from a site of active infection. The results of most
cultures are positive within 2 to 7 days, but they can
take up to 2 to 3 weeks due to the bacteria’s slow
growth.13 Testing by polymerase chain reaction is
currently being evaluated but not generally available
in practice.14 Both Nocardia and Actinomyces fail
to stain with classic, non-modified acid-fast stains.
However, Nocardia partially stains with acid-fast
staining when modified techniques are used. This
approach is useful for differentiating Nocardia
from Actinomyces, another gram-positive, thin,
branching, filamentous bacilli. Actinomyces may
present similarly to Nocardia, but the results of
modified acid-fast staining are classically negative
for Actinomyces.15 This fact suggests that the initial
staining results from the chest lesion should have
been interpreted as more concerning for Nocardia
than Actinomyces. However, there have been
rare reports of Actinomyces staining positive with
modified acid-fast staining.16 Another useful test to
differentiate these 2 organisms is anaerobic culture.
Actinomyces species will grow under anaerobic
conditions, but Nocardia are obligate aerobes.15 In
our case, an anaerobic culture of the chest lesion
may have helped providers arrive at the correct
diagnosis sooner.
First-line treatment for nocardiosis is sulfonamide
therapy,
with
trimethoprim-sulfamethoxazole
being the most commonly used agent. Several
alternative choices are effective against most
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Nocardia species, including amikacin, imipenem,
meropenem, ceftriaxone, cefotaxime, minocycline,
moxifloxacin, levofloxacin, linezolid, tigecycline,
and amoxicillin-clavulanic acid. In most cases,
combination therapy should be used to enhance
activity and decrease the possibility of developing
antibiotic resistance. In treating CNS disease,
antibiotics with favorable CNS penetration should
be selected. Sulfonamides, alone or combined
with trimethoprim, are most effective and typically
used first-line for at least 1 year. Combining
minocycline, imipenem, or aminoglycoside with a
third-generation cephalosporin may also be used
as alternative therapies.17
This case illustrates that a diagnostic dilemma
can arise when a rare condition presents in an
atypical population. Our patient presented with an
unusual infection and no clear exposure history.
Furthermore, the organism is more commonly seen
in immunocompromised hosts and is less likely to
present in immunocompetent patients. This detail
clearly affected the interpretation of the culture data
obtained from the patient’s chest mass, delaying
his appropriate treatment. While Nocardia is less
common, it is important to remember that more
than 30% of patients infected with Nocardia are
immunocompetent. Finally, multiple tests can help
differentiate Actinomyces from Nocardia when the
diagnosis is unclear and should be used when
possible.
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